Articles Published in 2013

Covance launches external laboratory management services

Wednesday, September 25, 2013 12:36 PM

CRO Covance has launched external laboratory management services, a new offering that provides biopharmaceutical companies with a management solution for external laboratory testing associated with clinical trials.

More... »

CMS Office of the Actuary projects modest growth in healthcare spending

Wednesday, September 25, 2013 12:35 PM

Consistent with past years’ findings, a report from the Centers for Medicare and Medicaid Services (CMS) Office of the Actuary projects U.S. healthcare spending growth over the next 10 years will be modest in comparison to historical trends, with increased spending the result of an improving economy and more accessible and affordable health coverage.

More... »

Chrysalis BioTherapeutics receives $1.5m from the National Cancer Institute

Wednesday, September 25, 2013 12:33 PM

Chrysalis BioTherapeutics has announced receipt of a $1.5 million contract from the National Cancer Institute (NCI) to continue its development of Chrysalin to mitigate radiotherapy-induced damage to normal brain tissue.

More... »

Servier makes offer for all shares of Egis Pharmaceuticals

Wednesday, September 25, 2013 12:31 PM

Servier Group has announced a voluntary public offer (to be made by its wholly-owned subsidiary Arts et Techniques du Progrès) to purchase all outstanding shares in its majority-owned subsidiary Egis Pharmaceuticals for $126 per share in cash.

More... »

Sysmex acquires Inostics

Wednesday, September 25, 2013 12:29 PM

Privately-held biotech company Indivumed, based in Hamburg, Germany, has announced that Inostics and its Baltimore-based subsidiary have been sold to Sysmex, a developer and manufacturer of instruments, reagents and software needed for in-vitro diagnostics, headquartered in Japan.

More... »

WCCT Global acquires OC Clinical Trials and Consulting

Wednesday, September 25, 2013 12:28 PM

WCCT Global, an Orange County, Calif.-based CRO, has acquired OC Clinical Trials and Consulting, an early stage ophthalmology and cosmetology research practice.

More... »

NCCN, McKesson Specialty Health, U.S. Oncology Network integrate with Elekta, Varian

Wednesday, September 25, 2013 12:26 PM

The National Comprehensive Cancer Network (NCCN), The U.S. Oncology Network and McKesson Specialty Health have inked agreements to provide future integration with Elekta and Varian that will enhance the ability to provide cancer patients with evidence-based quality care. The two oncology information systems are Elekta’s MOSAIQ and Varian’s ARIA.

More... »

AbbVie, Galapagos to co-develop cystic fibrosis therapies

Wednesday, September 25, 2013 12:24 PM

Galapagos and AbbVie have entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis (CF), an inherited chronic disease that affects 70,000 people worldwide.

More... »

PRA, RPS merger completed

Wednesday, September 25, 2013 12:23 PM

CRO PRA International has completed its merger with ReSearch Pharmaceutical Services (RPS) and the closing of the acquisition by Kohlberg Kravis Roberts.  

More... »

Janssen, PATH collaborate for Rilpivirine

Wednesday, September 25, 2013 12:21 PM

Janssen R&D Ireland has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 (HIV-1) medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis (PrEP) against HIV infection.

More... »